Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
The Danish biotech company confirmed the global study will begin in the second half of 2026
After Phase 3 results show major hair regrowth gains
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Subscribe To Our Newsletter & Stay Updated